Accuracy of a Single Tunnel Technique for Reconstruction of the Interosseous Talocalcaneal Ligament

by Patrick Bull DO, Jeffrey Weber DPM, Eric So DPM
Published 2018-09-01

Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al

by James Larkin, Jeffrey Weber, Paolo Antonio Ascierto, Mario Mandala
Published 2022-01-01

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastro...

by Scott Mitchell, John P Williams, Harsimrandeep Bhatti, Toufic Kachaamy, Jeffrey Weber, Glen J Weiss
Published 2017-01-01

Structures at Risk with Plantar Approach Retrograde First Metatarsal Charcot Beam Screw Insertion

by David Larson DPM, Christopher Reb DO, Christopher Hyer DPM, Patrick Bull DO, Jeffrey Weber DPM
Published 2017-09-01

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

by Rebecca J Critchley-Thorne, Ning Yan, Serban Nacu, Jeffrey Weber, Susan P Holmes, Peter P Lee
Published 2007-05-01

Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors

by Nicholas Gulati, Arda Celen, Paul Johannet, Janice M. Mehnert, Jeffrey Weber, Michelle Krogsgaard, Iman Osman, Judy Zhong
Published 2021-11-01

658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases

by Jeffrey Weber, Michelle Krogsgaard, Anna Pavlick, Mehmet Altan, Sabina Sandigursky, Safa Houssein, Xerxes Pundole, Elizaveta Efuni, Samuel Cytryn
Published 2020-11-01

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

by Douglas Donnelly, Shirin Bajaj, Jaehong Yu, Miles Hsu, Arjun Balar, Anna Pavlick, Jeffrey Weber, Iman Osman, Judy Zhong
Published 2019-08-01

A genome-wide association study of germline variation and melanoma prognosis

by Vylyny Chat, Vylyny Chat, Vylyny Chat, Sasha Dagayev, Sasha Dagayev, Sasha Dagayev, Una Moran, Una Moran, Matija Snuderl, Jeffrey Weber, Jeffrey Weber, Robert Ferguson, Robert Ferguson, Robert Ferguson, Iman Osman, Iman Osman, Iman Osman, Tomas Kirchhoff, Tomas Kirchhoff, Tomas Kirchhoff
Published 2023-01-01

308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

by Dirk Schadendorf, Mark Middleton, Jeffrey Weber, Delphine Hennicken, Paolo Ascierto, Andriy Moshyk, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati
Published 2020-11-01

Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.

by Jessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, Jeffrey J Molldrem, Amod Sarnaik, Shari Pilon-Thomas, Jeffrey Weber, Patrick Hwu, Laszlo Radvanyi
Published 2013-01-01

Tumor immunogenomic signatures improve a prognostic model of melanoma survival

by Leah Morales, Danny Simpson, Robert Ferguson, John Cadley, Eduardo Esteva, Kelsey Monson, Vylyny Chat, Carlos Martinez, Jeffrey Weber, Iman Osman, Tomas Kirchhoff
Published 2021-02-01

Intramedullary Screw Fixation and Relevant Diameter of the Proximal Phalanges of the Foot

by Roberto Brandao DPM, Bryan Van Dyke DO, Benjamin Watson DO, Jeffrey Weber DPM, David Larson DPM, Maria McGann DO, Christopher Hyer DPM
Published 2018-09-01

390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials

by Jeffrey Weber, Hassane Zarour, David Carbone, Marcus Butler, Roma Patel, Melissa Johnson, Adrian Sacher, Edward Garon, Arindam Dhar, Cristina Messina, Kristin Blouch, Axel Hoos, Anne-Marie Martin
Published 2021-11-01

681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors

by James White, Jarushka Naidoo, Jeffrey Weber, Evan Lipson, Cynthia Sears, Bertrand Routy, Fyza Shaikh, Joell Gills, Taiki Hakozaki, Richard Corentin, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jiyoung Ahn
Published 2020-11-01

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

by Laura C Cappelli, Maria E Suarez-Almazor, Michelle Turner, Stephane Champiat, Caroline Robert, Julie R Brahmer, Jarushka Naidoo, Jeffrey Weber, Joanne Riemer, Elad Sharon, Michael B Atkins, M Catherine Pietanza, Karthik Suresh, Catherine Murphy, Javid Moslehi, David Feltquate, Lee M Krug
Published 2023-03-01

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

by James Larkin, Harriet Kluger, Omid Hamid, Jeffrey Weber, Amod A Sarnaik, Brian Gastman, Jeffrey Chou, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Xiao Wu, Jason A Chesney, Giri Sulur, Friedrich Graf Finckenstein
Published 2023-11-01

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

by Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney
Published 2022-11-01

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint...

by Jessica C Hassel, James Larkin, Madan Jagasia, Harriet Kluger, Omid Hamid, Jeffrey Weber, Jason Chesney, Amod Sarnaik, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Karl D Lewis, Nikhil I Khushalani, Parameswaran Hari, Marlana Orloff, Mike Cusnir, Giao Q Phan, Andrew J S Furness, Michael E Egger, Friedrich Graf Finckenstein, Giri Sulur
Published 2022-12-01

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

by James Larkin, Jeffrey Weber, Victoria Atkinson, Michael Millward, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Helen Gogas, Paolo A Ascierto, Anna Maria Di Giacomo, Veerle de Pril, Vanna Chiarion-Sileni, Stephane Dalle, Leslie Fecher, Ana Arance, Jean-Jacques Grob, Nikhil I Khushalani, Michele Del Vecchio, Mario Mandala, C Lance Cowey, Michael Schenker, Petr Arenberger, Maurice Lobo
Published 2021-08-01